Feasibility of Testing Client Preferences for Accessing Injectable Opioid Agonist Treatment (iOAT): A Pilot Study https://t.co/oEdH5EIYR8 https://t.co/4mNCCh5KbR
Feasibility of Testing Client Preferences for Accessing Injectable Opioid Agonist Treatment (iOAT): A Pilot Study https://t.co/oEdH5EIYR8 https://t.co/AOCa12HzbO
Accessing Injectable Opioid Agonist Treatment | PPA @DovePress https://t.co/qEljI7glxW
Feasibility of Testing Client Preferences for Accessing Injectable Opioid Agonist Treatment (iOAT): A Pilot Study https://t.co/iBWF4VT7g5 https://t.co/G3kVZMh6HF
A Canadian study published today examines the potential benefits of intravenously administering opiate agonist medication e.g. diacetylmorphine or hydromorphone, on a daily basis in a controlled environment. https://t.co/XPds8DM5ce
Accessing Injectable Opioid Agonist Treatment https://t.co/vnQfI8ecsQ #breakingnews